Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
These treatments can result in significant muscle loss, likely due to evolutionary mechanisms protecting against food scarcity as muscle is a major energy utilizer
Semaglutide (STEP 1 trial): Participants lost an average of 14.9% of body weight over 68 weeks at the 2.4 mg dose, compared to 2.4% with placebo
All medications come from licensed 503A compounding pharmacies, with no insurance required and HSA/FSA eligibility
Gradual dose escalation helps the body adjust to treatment
US$ 27.19
US$ 28.42
US$ 26.51
